Renal denervation effective for treatment of refractory ventricular arrhythmias

Written By : Medha Baranwal |Medically Reviewed By : Dr. Kamal Kant Kohli Published On 2020-10-13T20:03:31+05:30 | Updated On 14 Oct 2020 2:43 PM IST

Australia: Renal denervation is an effective treatment for refractory ventricular arrhythmias (VA) or electrical storm (ES), suggests a recent study in the journal JACC: Clinical Electrophysiology.

Catheter ablation is effective for the treatment of structural heart disease ventricular tachycardia (VT) but still, there are some patients who have refractory VT despite multiple procedures. In this scenario, the doctors perform novel adjunctive therapies such as renal denervation. Joshua Hawson, Department of Cardiology, Royal Melbourne Hospital, Melbourne, Victoria, Australia, and colleagues performed a systematic review and meta-analysis of published data to determine whether renal denervation is effective in patients with refractory ventricular arrhythmias or electrical storm.

It included studies that evaluated patients undergoing RDN for VA or ES. Outcome measures of VA, sudden cardiac death, ES, or device therapy were required. It excluded case reports, editorials, and conference presentations.

The literature search helped in the identification of a total of 328 articles. Seven studies that met the eligibility criteria were included, with a total of 121 pooled patients. The weighted mean age was 63.8 ± 13.1 years, ejection fraction 30.5 ± 10.3%, 76% were men, 99% were on a beta-blocker, 79% were on amiodarone, 46% had previously undergone catheter ablation, and 8.3% had previously undergone cardiac sympathetic denervation.

Also Read: Short term use of HCQS not linked to lethal heart rhythms: ESC study

Key findings of the study include:

Meta-analysis demonstrated a significant effect of RDN in reducing implantable cardiac defibrillator therapies, with a standardized mean difference (SMD) of −3.11.
RDN also reduced the number of VA episodes (SMD −2.13), antitachycardia pacing episodes (SMD −2.82), and shocks (SMD −2.82).

"Further randomized trials are warranted to confirm the efficacy of RDN for the treatment of refractory VAs and electrical storm," concluded the authors.

Also Read: Use HCQS and azithromycin cautiously in COVID-19 patients with CVD: AHA

The study, "Renal Denervation for the Management of Refractory Ventricular Arrhythmias: A Systematic Review," is published in the journal JACC: Clinical Electrophysiology.

DOI: https://electrophysiology.onlinejacc.org/content/early/2020/09/26/j.jacep.2020.07.019

JACC: Clinical ElectrophysiologyRenal denervationarrhythmiaelectrical stormventricular tachycardia

Source : JACC: Clinical Electrophysiology

Medha Baranwal

MSc. Biotechnology

Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Dr. Kamal Kant Kohli

Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751